» Articles » PMID: 22814431

Selection and Characterisation of Guanidine-resistant Mutants of Human Enterovirus 71

Overview
Journal Virus Res
Specialty Microbiology
Date 2012 Jul 21
PMID 22814431
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The replication of human enterovirus 71 (HEV71) in cell culture is inhibited by concentrations of guanidine that do not have an observable adverse effect on host cell metabolism. Although the HEV71 non-structural protein 2C is known to play an important role in viral RNA replication, its precise biochemical activities and structure have not been fully determined. Here we describe amino acid substitutions in HEV71 protein 2C that confer resistance to guanidine. Three guanidine-resistant virus populations were independently isolated and found to contain five mutations in protein 2C, one of which, A4657T (2C-M193L), was present in two of the independently selected populations. This mutation was introduced into a HEV71 infectious cDNA clone and was sufficient to confer complete resistance to growth inhibition in the presence of 4mM guanidine. In the first guanidine-resistant population selected, the 2C-M193L mutation occurred in association with an additional mutation, A4459G (2C-I127V), located in the putative cis-acting replication element (cre) of coding region 2C. This mutation conferred only partial guanidine resistance when introduced into the HEV71-26M infectious clone. When the 2C-I127V and 2C-M193L mutations were introduced into HEV71-26M together, the 2C-I127V mutation did not increase the level of guanidine resistance due to the 2C-M193L mutation alone. This study confirms that guanidine resistance can be readily selected in HEV71 and is attributable to mutations within protein 2C.

Citing Articles

Enterovirus-A71 exploits RAB11 to recruit chaperones for virus morphogenesis.

Ng Q, Mahendran V, Lim Z, Tan J, Wong J, Chu J J Biomed Sci. 2024; 31(1):65.

PMID: 38943128 PMC: 11212238. DOI: 10.1186/s12929-024-01053-2.


Preventive effects of quercetin against foot-and-mouth disease virus and by inducing type I interferon.

Lee G, Kang H, Kim A, Park J, Lee M, Kim S Front Microbiol. 2023; 14:1121830.

PMID: 37250022 PMC: 10213290. DOI: 10.3389/fmicb.2023.1121830.


The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C.

Wang S, Wang K, Zhao K, Hua S, Du J Front Microbiol. 2020; 11:615965.

PMID: 33381104 PMC: 7767853. DOI: 10.3389/fmicb.2020.615965.


Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.

Bauer L, Manganaro R, Zonsics B, Hurdiss D, Zwaagstra M, Donselaar T PLoS Biol. 2020; 18(11):e3000904.

PMID: 33156822 PMC: 7673538. DOI: 10.1371/journal.pbio.3000904.


Enterovirus D68 Antivirals: Past, Present, and Future.

Hu Y, Musharrafieh R, Zheng M, Wang J ACS Infect Dis. 2020; 6(7):1572-1586.

PMID: 32352280 PMC: 8055446. DOI: 10.1021/acsinfecdis.0c00120.